QR-koda

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)

Introduction: Little is known about sex differences in lenvatinib treatment safety and efficacy. Methods: Real-word retrospective Italian multicenter study enrolling patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib. Results: A total of 138 patients (64 femal...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Giulia Puliani, Marta Bianchini, Carlotta Giani, Laura Valerio, Alice Nervo, Giulia Sapuppo, Giorgio Grani, Cristina Dalmiglio, Simone De Leo, Rosa Lauretta, Marilda Mormando, Irene Terrenato, Stefania Zovato, Laura Fugazzola, Maria Grazia Castagna, Cosimo Durante, Gabriella Pellegriti, Emanuela Arvat, Rossella Elisei, Marialuisa Appetecchia
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Bioscientifica 2025-04-01
Ráidu:European Thyroid Journal
Fáttát:
lenvatinib
sex
gender
efficacy
safety
radioiodine-refractory differentiated thyroid cancer
Liŋkkat:https://etj.bioscientifica.com/view/journals/etj/14/2/ETJ-24-0386.xml
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid